关注
Hamidreza Jamaati
Hamidreza Jamaati
在 sbmu.ac.ir 的电子邮件经过验证
标题
引用次数
引用次数
年份
Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries
G Bellani, JG Laffey, T Pham, E Fan, L Brochard, A Esteban, L Gattinoni, ...
Jama 315 (8), 788-800, 2016
48312016
Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study
JG Laffey, G Bellani, T Pham, E Fan, F Madotto, EK Bajwa, L Brochard, ...
Intensive care medicine 42, 1865-1876, 2016
3412016
Stress and burnout in health care workers during COVID-19 pandemic: validation of a questionnaire
N Talaee, M Varahram, H Jamaati, A Salimi, M Attarchi, ...
Journal of Public Health, 1-6, 2020
3072020
Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series
SMR Hashemian, R Aliannejad, M Zarrabi, M Soleimani, M Vosough, ...
Stem cell research & therapy 12, 1-12, 2021
1782021
Epidemiology and patterns of tracheostomy practice in patients with acute respiratory distress syndrome in ICUs across 50 countries
T Abe, F Madotto, T Pham, I Nagata, M Uchida, N Tamiya, K Kurahashi, ...
Critical care 22, 1-16, 2018
1452018
Anti-inflammatory effects of lactobacillus rahmnosus and bifidobacterium breve on cigarette smoke activated human macrophages
E Mortaz, IM Adcock, FLM Ricciardolo, M Varahram, H Jamaati, ...
PLoS One 10 (8), e0136455, 2015
1402015
Nitric oxide in the pathogenesis and treatment of tuberculosis
H Jamaati, E Mortaz, Z Pajouhi, G Folkerts, M Movassaghi, ...
Frontiers in microbiology 8, 2008, 2017
1192017
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study
JG Laffey, F Madotto, G Bellani, T Pham, E Fan, L Brochard, P Amin, ...
The Lancet Respiratory Medicine 5 (8), 627-638, 2017
1182017
Evaluating the effects of Intravenous Immunoglobulin (IVIg) on the management of severe COVID-19 cases: A randomized controlled trial
P Tabarsi, S Barati, H Jamaati, S Haseli, M Marjani, A Moniri, Z Abtahian, ...
International immunopharmacology 90, 107205, 2021
972021
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial
F Dastan, SA Nadji, A Saffaei, M Marjani, A Moniri, H Jamaati, ...
International immunopharmacology 85, 106688, 2020
902020
No clinical benefit of high dose corticosteroid administration in patients with COVID-19: a preliminary report of a randomized clinical trial
H Jamaati, SMR Hashemian, B Farzanegan, M Malekmohammad, ...
European Journal of Pharmacology 897, 173947, 2021
862021
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis
MV Maddali, M Churpek, T Pham, E Rezoagli, H Zhuo, W Zhao, J He, ...
The lancet respiratory medicine 10 (4), 367-377, 2022
792022
Increased serum levels of soluble TNF-α receptor is associated with ICU mortality in COVID-19 patients
E Mortaz, P Tabarsi, H Jamaati, N Dalil Roofchayee, NK Dezfuli, ...
Frontiers in Immunology 12, 592727, 2021
752021
Effect of the Cardio First Angel™ device on CPR indices: a randomized controlled clinical trial
A Vahedian-Azimi, M Hajiesmaeili, A Amirsavadkouhi, H Jamaati, M Izadi, ...
Critical Care 20, 1-8, 2016
702016
Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study
T Pham, L Heunks, G Bellani, F Madotto, I Aragao, G Beduneau, ...
The Lancet Respiratory Medicine 11 (5), 465-476, 2023
682023
Resolved versus confirmed ARDS after 24 h: insights from the LUNG SAFE study
F Madotto, T Pham, G Bellani, LD Bos, FD Simonis, E Fan, A Artigas, ...
Intensive care medicine 44, 564-577, 2018
662018
Promising effects of tocilizumab in COVID-19: a non-controlled, prospective clinical trial
F Dastan, A Saffaei, S Haseli, M Marjani, A Moniri, Z Abtahian, A Abedini, ...
International immunopharmacology 88, 106869, 2020
632020
COVID-19: molecular and cellular response
SD Alipoor, E Mortaz, H Jamaati, P Tabarsi, H Bayram, M Varahram, ...
Frontiers in cellular and infection microbiology 11, 563085, 2021
562021
A fourteen-day experience with coronavirus disease 2019 (COVID-19) induced acute respiratory distress syndrome (ARDS): an Iranian treatment protocol
H Jamaati, F Dastan, P Tabarsi, M Marjani, A Saffaei, SMR Hashemian
Iranian Journal of Pharmaceutical Research: IJPR 19 (1), 31, 2020
522020
Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS)
SMR Hashemian, N Shafigh, G Afzal, H Jamaati, P Tabarsi, M Marjani, ...
Pulmonology 27 (6), 486-492, 2021
492021
系统目前无法执行此操作,请稍后再试。
文章 1–20